How the TPP Trade Deal Could Increase Risk of Dying of Breast Cancer
On the surface, the fear and urgency of a new breast cancer diagnosis seems far removed from a huge international trade deal. And yet, as the executive director of Breast Cancer Action, I am acutely aware of how the highly contested Trans-Pacific Partnership (TPP) threatens the health and well-being of women.
Photo credit: Shutterstock
Although negotiations between the world's biggest economic players can feel disconnected and distant from the day-to-day issues of women living with or at risk of breast cancer, the truth is these massive multinational trade deals play out in ways that directly impact all of us. These impacts include restricting access to affordable cancer treatments and increasing our exposure to chemicals that increase our risk of cancer.
The TPP is a sweeping free trade deal negotiated in secret by the U.S. and 11 other Asian and European countries, with the “help" of more than 600 corporate advisors, including institutions and corporations that produce policies or products linked to breast cancer, like the American Chemistry Council, Avon and Chevron. Yet, while these multibillion dollar giants have a seat at the table, the public is forced to rely only on leaked snippets of information about the trade deal that will impact many aspects of our lives—and bodies.
And as if the secretive and back room deal politicking isn't bad enough, President Obama has asked Congress to give him authority to quickly pass, or “fast-track," the deal. Yesterday the Senate said "no" to moving forward with Fast Track—and we must keep the pressure on.
As the head of a watchdog organization for the breast cancer movement, I work to ensure that public health and patient interests come before those of big business—and I say no way to secret trade deals that harm our health and well-being, especially when we have no say in the matter. I am outraged that information revealed so far about the TPP shows that while it will be great for multinational corporations, it would be, as is too often the case, terrible for our health.
The TPP both threatens access to affordable treatments and limits regulation that protects the public from toxic exposures and processes. This means that not only will more people be exposed to chemicals that are known and suspected to cause health harm, but the treatments for these medical problems will be more expensive as a result of the TPP.
Cost of treatment for breast cancer (and other) patients is a critical issue in the U.S. Too many women already experience first-hand the exorbitant cost of cancer drugs in the U.S.: 11 out of the 12 cancer drugs approved by the U.S. Food and Drug Administration (FDA) in 2012 cost more than $100,000 per year. The current U.S. patent system is designed to reward drug companies for introducing new treatments by providing them with a period of exclusivity, during which no other drug company can sell a competing or generic version of that drug.
The Obama administration once acknowledged that an important step in making cancer treatments more affordable is by limiting this period of exclusivity so that generic options can come onto the market more quickly and provide cancer patients with affordable treatments options. Despite this, the administration is reportedly pushing for market exclusivity periods to last 12 years.
According to language in the TPP's leaked intellectual property chapter, the trade deal would require all participating countries to enact automatic market exclusivity periods on many essential medical drugs, including biological therapies used to treat cancer. In this way, no country would be able to take action within their borders to bring down the cost of treatment by reforming the patent system or reducing the period of exclusivity. It could also limit the U.S. government from negotiating with pharmaceutical companies for lower prices and better reimbursements for patients requiring Medicaid and Medicare. And it would spell disaster for developing countries signing on to the deal.
By locking all 12 nations into patents with long exclusivity periods, the TPP removes any chance for participating countries to take action to reduce the cost of breast cancer and other medical treatments. The TPP would limit access to life-saving treatment by keeping drug prices high—and out of reach of too many patients. This is unacceptable and wrong.
The TPP will include an “Investor-State Dispute Settlement" (ISDS) provision, which allows international investors—mainly multinational corporations—to sue a country if its laws interfere with their profits. Corporations are able to bypass domestic courts and go before an international tribunal of private lawyers, who can, in turn, force nations to pay compensation or “reparation" to corporations—sometimes handing over millions in taxpayer dollars. While ISDS is a provision in many international trade agreements, the TPP expands the current reach of ISDS to thousands of corporations in the twelve countries signing on to the trade deal.
Currently, the nation's fifth-largest pharmaceutical company, Eli Lilly, is using an ISDS to challenge Canada's drug approval process. After finding that one of Eli Lilly's drugs was not effective, Canada invalidated one of its drug patents. In response, Ely Lilly is attempting to use the ISDS provision under the North American Free Trade Agreement (NAFTA) to sue Canada for $500 million. The TPP threatens to expand the power of pharmaceutical corporations like Eli Lilly to set and maintain high drug costs—and high profits at the expense of patient well-being.
Not only do the TPP and its ISDS provision threaten to keep the costs of breast cancer treatments high, this trade deal will also erode efforts to stop cancer before it starts—meaning more and more people may need these exorbitantly expensive cancer treatments.
Health activists, environmental justice activists, and healthcare professionals have long sought strong chemical policy reform in the U.S. to limits exposures to toxic chemicals—some of which have been linked to breast cancer—in consumer, personal care, and household products. While we have a long way to go to strengthen the Toxic Substance Control Act (TSCA) and other chemical regulatory policies, the TPP would enable countries importing goods to the U.S. to bypass our existing chemical safety regulations. As a result of ISDS, countries signing on to the TPP won't be held to U.S. standards for chemical safety when importing their goods here.
Similarly, activists across the country have been fighting for both local and national bans on fracking, a process using many chemicals linked to breast cancer and other health harms. But because of ISDS, foreign oil and gas corporations could sue the U.S. if they assert that our fracking bans interfere with their profit – thus undermining the important work the anti-fracking movement is doing in the U.S. to limit its toxic impact.
We must take a stand and demand public health comes before corporate profit. We must stand against the TPP which blatantly and unapologetically shifts power away from people and toward corporations. Not only would the TPP block vital work to reduce toxic exposures that increase our risk of breast cancer in the first place, the TPP threatens access to affordable and effective treatments for women who are diagnosed with breast cancer.
Now is the time to tell our Congressional representatives: Don't trade away our health.
YOU MIGHT ALSO LIKE
A tornado tore through a city north of Birmingham, Alabama, Monday night, killing one person and injuring at least 30.
- Tornadoes and Climate Change: What Does the Science Say ... ›
- Tornadoes Hit Unusually Wide Swaths of U.S., Alarming Climate ... ›
- 23 Dead as Tornado Pummels Lee County, AL in Further Sign ... ›
EcoWatch Daily Newsletter
By David Konisky
On his first day in office President Joe Biden started signing executive orders to reverse Trump administration policies. One sweeping directive calls for stronger action to protect public health and the environment and hold polluters accountable, including those who "disproportionately harm communities of color and low-income communities."
Michael S. Regan, President Biden's nominee to lead the U.S. Environmental Protection Agency, grew up near a coal-burning power plant in North Carolina and has pledged to "enact an environmental justice framework that empowers people in all communities." NCDEQ
- Report Urges Biden to Reverse Trump's Environmental Rollbacks ›
- US Environmental Protection Agency (EPA) ›
- Biden's EPA Pick Michael Regan Urged to Address Environmental ... ›
- Biden Faces Pressure to Tackle 'Unfunded' Toxic Waste Sites ... ›
By Katherine Kornei
Clear-cutting a forest is relatively easy—just pick a tree and start chopping. But there are benefits to more sophisticated forest management. One technique—which involves repeatedly harvesting smaller trees every 30 or so years but leaving an upper story of larger trees for longer periods (60, 90, or 120 years)—ensures a steady supply of both firewood and construction timber.
A Pattern in the Rings<p>The <a href="https://www.encyclopedia.com/science/dictionaries-thesauruses-pictures-and-press-releases/coppice-standards-0" target="_blank">coppice-with-standards</a> management practice produces a two-story forest, said <a href="https://www.researchgate.net/profile/Bernhard_Muigg" target="_blank">Bernhard Muigg</a>, a dendrochronologist at the University of Freiburg in Germany. "You have an upper story of single trees that are allowed to grow for several understory generations."</p><p>That arrangement imprints a characteristic tree ring pattern in a forest's upper story trees (the "standards"): thick rings indicative of heavy growth, which show up at regular intervals as the surrounding smaller trees are cut down. "The trees are growing faster," said Muigg. "You can really see it with your naked eye."</p><p>Muigg and his collaborators characterized that <a href="https://ltrr.arizona.edu/about/treerings" target="_blank">dendrochronological pattern</a> in 161 oak trees growing in central Germany, one of the few remaining sites in Europe with actively managed coppice-with-standards forests. They found up to nine cycles of heavy growth in the trees, the oldest of which was planted in 1761. The researchers then turned to a historical data set — more than 2,000 oak <a href="https://eos.org/articles/podcast-discovering-europes-history-through-its-timbers" target="_blank" rel="noopener noreferrer">timbers from buildings and archaeological sites</a> in Germany and France dating from between 300 and 2015 — to look for a similar pattern.</p>
A Gap of 500 Years<p>The team found wood with the characteristic coppice-with-standards tree ring pattern dating to as early as the 6th century. That was a surprise, Muigg and his colleagues concluded, because the first mention of this forest management practice in historical documents occurred only roughly 500 years later, in the 13th century.</p><p>It's probable that forest management practices were not well documented prior to the High Middle Ages (1000–1250), the researchers suggested. "Forests are mainly mentioned in the context of royal hunting interests or donations," said Muigg. Dendrochronological studies are particularly important because they can reveal information not captured by a sparse historical record, he added.</p><p>These results were <a href="https://www.nature.com/articles/s41598-020-78933-8" target="_blank">published in December in <em>Scientific Reports</em></a>.</p><p>"It's nice to see the longevity and the history of coppice-with-standards," said <a href="https://www.teagasc.ie/contact/staff-directory/s/ian-short/" target="_blank">Ian Short</a>, a forestry researcher at Teagasc, the Agriculture and Food Development Authority in Ireland, not involved in the research. This technique is valuable because it promotes conservation and habitat biodiversity, Short said. "In the next 10 or 20 years, I think we'll see more coppice-with-standards coming back into production."</p><p>In the future, Muigg and his collaborators hope to analyze a larger sample of historic timbers to trace how the coppice-with-standards practice spread throughout Europe. It will be interesting to understand where this technique originated and how it propagated, said Muigg, and there are plenty of old pieces of wood waiting to be analyzed. "There [are] tons of dendrochronological data."</p><p><em><a href="mailto:email@example.com" target="_blank" rel="noopener noreferrer">Katherine Kornei</a> is a freelance science journalist covering Earth and space science. Her bylines frequently appear in Eos, Science, and The New York Times. Katherine holds a Ph.D. in astronomy from the University of California, Los Angeles.</em></p><p><em>This story originally appeared in <a href="https://eos.org/articles/tree-rings-reveal-how-ancient-forests-were-managed" target="_blank">Eos</a></em> <em>and is republished here as part of Covering Climate Now, a global journalism collaboration strengthening coverage of the climate story.</em></p>
Earth's ice is melting 57 percent faster than in the 1990s and the world has lost more than 28 trillion tons of ice since 1994, research published Monday in The Cryosphere shows.
By Jewel Fraser
Noreen Nunez lives in a middle-class neighborhood that rises up a hillside in Trinidad's Tunapuna-Piarco region.